Fumaric Acid

Fumaric Acid

SCHEMBL1782498

O=C(Nc1cnc(N2CCN3CCC2C3)nc1)c1ccccc1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNH2 known ✓ Q12809 1/20 0.39
ALKBH1 Q13686 1/20 0.44
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
LPAR3 Q9UBY5 1/20 0.40
BCAT2 O15382 2/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KCNQ3 O43525 1/20 0.39
KCNQ2 O43526 1/20 0.39
P4HTM Q9NXG6 1/20 0.39
MCHR1 Q99705 1/20 0.39
KDR P35968 1/20 0.38
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PKM P14618 1/20 0.37
PTPN11 Q06124 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1783138 0.95 ALKBH1 (0.48) ALKBH1BCAT2NPC1RAB9AKCNQ3
SCHEMBL2063619 0.88 ALKBH1 (0.50) ALKBH1BCAT2NPC1RAB9AKCNQ3
Hydrochloric Acid SCHEMBL2063475 0.87 ALKBH1 (0.49) ALKBH1BCAT2NPC1RAB9AKCNQ3
SCHEMBL4085016 0.79 HTR1F (0.50) NPC1RAB9AKCNQ3KCNQ2P4HTM
Hydrochloric Acid SCHEMBL4091202 0.78 HTR1F (0.49) NPC1RAB9AKCNQ3KCNQ2P4HTM
SCHEMBL4084213 0.77 KCNQ3 (0.49) MAPTRAB9AKCNQ3KCNQ2P4HTM
SCHEMBL4089385 0.77 KMT2A (0.43) ALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL4094577 0.76 KMT2A (0.43) ALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL4086359 0.76 KCNQ3 (0.48) MAPTRAB9AKCNQ3KCNQ2P4HTM
SCHEMBL4090589 0.76 KCNQ3 (0.56) ALDH1A1MAPTNPC1RAB9AKCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118268-A1 NOVEL 1,4-DIAZA-BICYCLO[3.2.1]OCTANE DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS NEUROSEARCH A/S (DK) 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118268-A1 NOVEL 1,4-DIAZA-BICYCLO[3.2.1]OCTANE DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS CHRNA6, CHRNA2, CHRNA10 KCNH2 613/4885ALKBH1 2314/4885ALDH1A1 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.